Company: FTII
Filing Date: 2025-04-09
Form Type: 10-K
Source: 0001641172-25-003384
Chunk: 948

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-04-09
Form: 10-K
Item: Item 3
Chunk 948
---
 and the transactions contemplated thereby and (ii) be bound by certain
other covenants and agreements related to the Transactions. The Voting Stockholder holds sufficient shares of Longevity to cause the
approval of the Transactions on behalf of Longevity.

In
connection with the execution of the Merger Agreement, the Company, the Sponsor has entered into a Voting and Support Agreement (the
“Sponsor Support Agreement”). The Sponsor Support Agreement provides that the Sponsor agrees (i) to vote in favor of the
proposed transactions contemplated by the Merger Agreement, (ii) to appear at the purchaser special meeting for purposes of constituting
a quorum, (iii) to vote against any proposals that would materially impede the proposed transactions contemplated by the Merger Agreement,
(iv) to not redeem any shares of the Company’s Common Stock held by it that may be redeemed, and (v) to waive any adjustment to
the conversion ratio set forth in the Company’s amended and restated certificate of incorporation (as amended from time to time,
the “Charter”) with respect to shares of the Class B Common Stock of the Company held by the Sponsor, in each case, on the
terms and subject to the conditions set forth in the Sponsor Support Agreement.

On
September 20, 2024, the Company filed a Form 8-K with the SEC to report the Merger Agreement and other legal agreements relating to the
Longevity Business Combination, and on February 14, 2025, the Company filed with the SEC an initial Form S-4 (Registration/Proxy Statement)
regarding the Longevity Business Combination (collectively, the “Longevity Disclosure Statements”). Unless specifically stated,
this Annual Report on Form 10-K does not give effect to the proposed Transactions and does not contain the risks associated with the
proposed transactions. For such information, please see Longevity Disclosure Statements.

Class
B Common Stock

Immediately
following the Third Extension Meeting and filing of the Third Charter Amendment with the Secretary of State of the State of Delaware,
on November 22, 2024, the holders of shares of Class B Common Stock unanimously elected to convert all of their shares of Class B Common
Stock to shares of Class A Common Stock on a one-to-one basis. As a result, all of 2,875,000 shares of Class B Common Stock issued and
outstanding have been converted to 2,875,000 shares of Class A Common Stock (the “Converted Class A Common Stock”) effective